22:33:02 EDT Thu 25 Apr 2024
Enter Symbol
or Name
USA
CA



Merus Labs International Inc (2)
Symbol MSL
Shares Issued 101,226,091
Close 2015-05-25 C$ 2.95
Market Cap C$ 298,616,968
Recent Sedar Documents

Merus Labs appoints Rotmann VP, head of European ops

2015-05-26 11:32 ET - News Release

Mr. Barry Fishman reports

MERUS LABS APPOINTS FRANK ROTMANN VP & HEAD OF EUROPEAN OPERATIONS

Merus Labs International Inc. has appointed Frank Rotmann as vice-president and head of European operations, effective today.

Based in Zurich, Switzerland, Mr. Rotmann has over 20 years of experience in the pharmaceutical industry. Most recently, he held the position of vice-president for central Eastern Europe for Takeda Pharmaceuticals. Previously, Mr. Rotmann held both country and regional responsibilities with full profit and loss accountability, and has a strong record of transforming businesses to profitable growth.

Mr. Rotmann has also held European and United States-based leadership roles at Eli Lilly, Sanofi, Altana and Nycomed, and has a master of business and engineering degree from the Karlsruhe Institute of Technology in Germany.

"We are thrilled to welcome Frank to the Merus executive team," said Barry Fishman, chief executive officer. "His deep knowledge of pharmaceutical life cycle management and results-driven approach will be valuable assets to take our European business to the next level."

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.